nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—Parkinson's disease	0.696	1	CbGaD
Pranlukast—MUC2—hindbrain—Parkinson's disease	0.00999	0.149	CbGeAlD
Pranlukast—MUC2—embryo—Parkinson's disease	0.00625	0.0935	CbGeAlD
Pranlukast—MUC2—brainstem—Parkinson's disease	0.00572	0.0857	CbGeAlD
Pranlukast—MUC2—forebrain—Parkinson's disease	0.00552	0.0827	CbGeAlD
Pranlukast—MUC2—spinal cord—Parkinson's disease	0.00356	0.0533	CbGeAlD
Pranlukast—MUC2—head—Parkinson's disease	0.00316	0.0474	CbGeAlD
Pranlukast—NFKB1—forebrain—Parkinson's disease	0.00315	0.0471	CbGeAlD
Pranlukast—MUC2—nervous system—Parkinson's disease	0.003	0.0449	CbGeAlD
Pranlukast—MUC2—central nervous system—Parkinson's disease	0.00289	0.0432	CbGeAlD
Pranlukast—MUC2—cerebellum—Parkinson's disease	0.00282	0.0422	CbGeAlD
Pranlukast—NFKB1—cardiovascular system—Parkinson's disease	0.00266	0.0399	CbGeAlD
Pranlukast—MUC2—brain—Parkinson's disease	0.00229	0.0343	CbGeAlD
Pranlukast—NFKB1—head—Parkinson's disease	0.0018	0.027	CbGeAlD
Pranlukast—CYSLTR1—head—Parkinson's disease	0.00177	0.0265	CbGeAlD
Pranlukast—NFKB1—nervous system—Parkinson's disease	0.00171	0.0256	CbGeAlD
Pranlukast—CYSLTR1—nervous system—Parkinson's disease	0.00168	0.0251	CbGeAlD
Pranlukast—NFKB1—central nervous system—Parkinson's disease	0.00165	0.0246	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—Parkinson's disease	0.00162	0.0242	CbGeAlD
Pranlukast—NFKB1—cerebellum—Parkinson's disease	0.00161	0.0241	CbGeAlD
Pranlukast—NFKB1—brain—Parkinson's disease	0.00131	0.0196	CbGeAlD
Pranlukast—CYSLTR1—brain—Parkinson's disease	0.00128	0.0192	CbGeAlD
Pranlukast—CYP2C9—cardiovascular system—Parkinson's disease	0.000697	0.0104	CbGeAlD
Pranlukast—CYP3A4—nervous system—Parkinson's disease	0.000341	0.0051	CbGeAlD
Pranlukast—CYP3A4—central nervous system—Parkinson's disease	0.000328	0.00491	CbGeAlD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—Parkinson's disease	8.41e-05	0.000355	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—Parkinson's disease	8.35e-05	0.000352	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GRM5—Parkinson's disease	8.34e-05	0.000352	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	8.34e-05	0.000352	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	8.3e-05	0.00035	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD1—Parkinson's disease	8.28e-05	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—Parkinson's disease	8.26e-05	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	8.26e-05	0.000349	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—Parkinson's disease	8.21e-05	0.000346	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—Parkinson's disease	8.12e-05	0.000343	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ADRBK1—Parkinson's disease	8.08e-05	0.000341	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD3—Parkinson's disease	8.02e-05	0.000338	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MAPK8—Parkinson's disease	7.99e-05	0.000337	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.88e-05	0.000332	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—DCTN1—Parkinson's disease	7.86e-05	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	7.85e-05	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—Parkinson's disease	7.79e-05	0.000329	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—EDN1—Parkinson's disease	7.77e-05	0.000328	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	7.73e-05	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—MAPK8—Parkinson's disease	7.67e-05	0.000323	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—CP—Parkinson's disease	7.63e-05	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	7.61e-05	0.000321	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HSPA8—Parkinson's disease	7.6e-05	0.000321	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRBK1—Parkinson's disease	7.49e-05	0.000316	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ABL1—Parkinson's disease	7.46e-05	0.000315	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—Parkinson's disease	7.43e-05	0.000314	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	7.4e-05	0.000312	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—MAPK8—Parkinson's disease	7.37e-05	0.000311	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	7.36e-05	0.00031	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	7.34e-05	0.00031	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGF20—Parkinson's disease	7.31e-05	0.000308	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	7.31e-05	0.000308	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—Parkinson's disease	7.27e-05	0.000307	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD2—Parkinson's disease	7.25e-05	0.000306	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR7—Parkinson's disease	7.25e-05	0.000306	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.24e-05	0.000305	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.21e-05	0.000304	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	7.21e-05	0.000304	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DRA—Parkinson's disease	7.15e-05	0.000301	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—DLG4—Parkinson's disease	7.13e-05	0.000301	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADORA2A—Parkinson's disease	7.09e-05	0.000299	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	7.09e-05	0.000299	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PLA2G6—Parkinson's disease	7.07e-05	0.000298	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CASP3—Parkinson's disease	7.07e-05	0.000298	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EDN1—Parkinson's disease	7.05e-05	0.000298	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	7.05e-05	0.000297	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	7.03e-05	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—Parkinson's disease	7.01e-05	0.000296	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GRIN2B—Parkinson's disease	6.97e-05	0.000294	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RIT2—Parkinson's disease	6.89e-05	0.000291	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	6.86e-05	0.000289	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—Parkinson's disease	6.8e-05	0.000287	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	6.72e-05	0.000283	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	6.71e-05	0.000283	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—Parkinson's disease	6.64e-05	0.00028	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—CASP3—Parkinson's disease	6.63e-05	0.000279	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.62e-05	0.000279	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—Parkinson's disease	6.59e-05	0.000278	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ABL1—Parkinson's disease	6.59e-05	0.000278	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INSR—Parkinson's disease	6.54e-05	0.000276	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRK5—Parkinson's disease	6.53e-05	0.000275	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—Parkinson's disease	6.52e-05	0.000275	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	6.52e-05	0.000275	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MAPK8—Parkinson's disease	6.5e-05	0.000274	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PARK2—Parkinson's disease	6.46e-05	0.000272	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF20—Parkinson's disease	6.4e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—Parkinson's disease	6.33e-05	0.000267	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—Parkinson's disease	6.3e-05	0.000266	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FGB—Parkinson's disease	6.19e-05	0.000261	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—Parkinson's disease	6.17e-05	0.00026	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1A—Parkinson's disease	6.15e-05	0.00026	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.14e-05	0.000259	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MAPK8—Parkinson's disease	6.09e-05	0.000257	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF2—Parkinson's disease	6.08e-05	0.000256	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TAC1—Parkinson's disease	6.06e-05	0.000256	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.98e-05	0.000252	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD1—Parkinson's disease	5.94e-05	0.000251	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	5.94e-05	0.000251	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1R—Parkinson's disease	5.88e-05	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—Parkinson's disease	5.87e-05	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRM4—Parkinson's disease	5.86e-05	0.000247	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EDN1—Parkinson's disease	5.81e-05	0.000245	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	5.8e-05	0.000245	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	5.79e-05	0.000244	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD3—Parkinson's disease	5.76e-05	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	5.71e-05	0.000241	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ABL1—Parkinson's disease	5.68e-05	0.00024	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CASP3—Parkinson's disease	5.68e-05	0.00024	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—MAPK8—Parkinson's disease	5.57e-05	0.000235	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—COMT—Parkinson's disease	5.56e-05	0.000235	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PENK—Parkinson's disease	5.55e-05	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAG—Parkinson's disease	5.55e-05	0.000234	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	5.54e-05	0.000234	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	5.53e-05	0.000233	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.5e-05	0.000232	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	5.49e-05	0.000231	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	5.46e-05	0.00023	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—Parkinson's disease	5.44e-05	0.00023	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.44e-05	0.000229	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.42e-05	0.000228	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRBK1—Parkinson's disease	5.37e-05	0.000227	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NGF—Parkinson's disease	5.34e-05	0.000225	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.22e-05	0.00022	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—MAPK8—Parkinson's disease	5.22e-05	0.00022	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD2—Parkinson's disease	5.2e-05	0.00022	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR7—Parkinson's disease	5.2e-05	0.00022	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—Parkinson's disease	5.16e-05	0.000218	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	5.09e-05	0.000215	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—Parkinson's disease	5.08e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDYN—Parkinson's disease	5.08e-05	0.000214	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	5.02e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—INS—Parkinson's disease	4.93e-05	0.000208	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	4.9e-05	0.000206	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	4.84e-05	0.000204	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.78e-05	0.000201	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GFAP—Parkinson's disease	4.78e-05	0.000201	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—Parkinson's disease	4.77e-05	0.000201	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GRM5—Parkinson's disease	4.72e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—Parkinson's disease	4.72e-05	0.000199	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ADRBK1—Parkinson's disease	4.71e-05	0.000199	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—Parkinson's disease	4.71e-05	0.000198	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—Parkinson's disease	4.66e-05	0.000196	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.54e-05	0.000191	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	4.53e-05	0.000191	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.43e-05	0.000187	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.37e-05	0.000184	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF2—Parkinson's disease	4.36e-05	0.000184	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.36e-05	0.000184	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK8—Parkinson's disease	4.27e-05	0.00018	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1R—Parkinson's disease	4.22e-05	0.000178	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EDN1—Parkinson's disease	4.17e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF20—Parkinson's disease	4.14e-05	0.000175	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.13e-05	0.000174	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—INS—Parkinson's disease	4.03e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADORA2A—Parkinson's disease	4.02e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ABL1—Parkinson's disease	3.84e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.83e-05	0.000162	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NGF—Parkinson's disease	3.83e-05	0.000162	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—INS—Parkinson's disease	3.76e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INSR—Parkinson's disease	3.71e-05	0.000156	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.67e-05	0.000155	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.65e-05	0.000154	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—Parkinson's disease	3.65e-05	0.000154	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.64e-05	0.000154	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.62e-05	0.000153	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MCCC1—Parkinson's disease	3.61e-05	0.000152	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ND3—Parkinson's disease	3.61e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HGF—Parkinson's disease	3.61e-05	0.000152	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.6e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—Parkinson's disease	3.56e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGB—Parkinson's disease	3.5e-05	0.000148	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1A—Parkinson's disease	3.48e-05	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAC1—Parkinson's disease	3.43e-05	0.000145	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.39e-05	0.000143	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—OMD—Parkinson's disease	3.39e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—Parkinson's disease	3.39e-05	0.000143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—Parkinson's disease	3.39e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD1—Parkinson's disease	3.36e-05	0.000142	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.36e-05	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—Parkinson's disease	3.34e-05	0.000141	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.31e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD3—Parkinson's disease	3.26e-05	0.000137	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.22e-05	0.000136	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.07e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRBK1—Parkinson's disease	3.04e-05	0.000128	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CASP3—Parkinson's disease	3e-05	0.000127	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—Parkinson's disease	2.98e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK8—Parkinson's disease	2.98e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD2—Parkinson's disease	2.95e-05	0.000124	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR7—Parkinson's disease	2.95e-05	0.000124	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INS—Parkinson's disease	2.9e-05	0.000122	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.77e-05	0.000117	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK8—Parkinson's disease	2.76e-05	0.000116	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.73e-05	0.000115	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DBH—Parkinson's disease	2.73e-05	0.000115	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GBA—Parkinson's disease	2.73e-05	0.000115	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—Parkinson's disease	2.73e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—Parkinson's disease	2.67e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF2—Parkinson's disease	2.47e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1R—Parkinson's disease	2.39e-05	0.000101	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ND3—Parkinson's disease	2.38e-05	0.0001	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.38e-05	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDN1—Parkinson's disease	2.36e-05	9.95e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—OMD—Parkinson's disease	2.24e-05	9.44e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.24e-05	9.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NGF—Parkinson's disease	2.17e-05	9.14e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP3—Parkinson's disease	2.16e-05	9.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—Parkinson's disease	2.15e-05	9.08e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—Parkinson's disease	2.14e-05	9.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.12e-05	8.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—Parkinson's disease	2.06e-05	8.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.02e-05	8.53e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DDC—Parkinson's disease	2.01e-05	8.47e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK8—Parkinson's disease	1.98e-05	8.36e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—Parkinson's disease	1.92e-05	8.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—Parkinson's disease	1.9e-05	8.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.9e-05	7.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—Parkinson's disease	1.89e-05	7.98e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.87e-05	7.89e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GBA—Parkinson's disease	1.8e-05	7.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DBH—Parkinson's disease	1.8e-05	7.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.8e-05	7.61e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—Parkinson's disease	1.76e-05	7.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK8—Parkinson's disease	1.73e-05	7.32e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.71e-05	7.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.69e-05	7.13e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—Parkinson's disease	1.64e-05	6.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INS—Parkinson's disease	1.64e-05	6.91e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.61e-05	6.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DDC—Parkinson's disease	1.32e-05	5.58e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—Parkinson's disease	1.27e-05	5.34e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	5.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.25e-05	5.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.23e-05	5.2e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP3—Parkinson's disease	1.22e-05	5.15e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	4.84e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.14e-05	4.79e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.13e-05	4.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK8—Parkinson's disease	1.12e-05	4.73e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TH—Parkinson's disease	1.12e-05	4.72e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.11e-05	4.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—Parkinson's disease	1.11e-05	4.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.07e-05	4.53e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COMT—Parkinson's disease	9.52e-06	4.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.47e-06	3.99e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.45e-06	3.99e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.34e-06	3.94e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—Parkinson's disease	8.97e-06	3.78e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—Parkinson's disease	8.7e-06	3.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.33e-06	3.52e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.28e-06	3.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.13e-06	3.43e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—Parkinson's disease	7.69e-06	3.24e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.57e-06	3.19e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.49e-06	3.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TH—Parkinson's disease	7.38e-06	3.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—Parkinson's disease	7.16e-06	3.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—Parkinson's disease	7.16e-06	3.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYCS—Parkinson's disease	7.09e-06	2.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COMT—Parkinson's disease	6.28e-06	2.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.25e-06	2.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.23e-06	2.63e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.16e-06	2.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INS—Parkinson's disease	6.12e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.91e-06	2.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.74e-06	2.42e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.5e-06	2.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5.07e-06	2.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—Parkinson's disease	4.72e-06	1.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INS—Parkinson's disease	4.03e-06	1.7e-05	CbGpPWpGaD
